{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:43:56Z","timestamp":1792424636494,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4723,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1046\/j.1523-1755.2003.00720.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:52:16Z","timestamp":1047462736000},"page":"248-254","source":"Crossref","is-referenced-by-count":192,"title":["The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism"],"prefix":"10.1016","volume":"63","author":[{"given":"Jill S.","family":"Lindberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack W.","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Blaisdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 73","key":"10.1046\/j.1523-1755.2003.00720.x_bb0010","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"56","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archinte.1969.00300200043008","article-title":"Secondary hyperparathyroidism in chronic renal failure","volume":"124","author":"Massry","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0020","first-page":"219","article-title":"Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia","volume":"14","author":"Massry","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0272-6386(97)90484-4","article-title":"Effects of excess PTH on nonclassical target organs","volume":"30","author":"Bro","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.290.6464.271","article-title":"Who gets renal bone disease before beginning dialysis?","volume":"290","author":"Cundy","year":"1985","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end stage renal failure \u2013 An evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0060","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-\u03b1-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of PTH in patients with hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0065","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2001.0590031187.x","article-title":"Recent developments in the management of secondary hyperparathyroidism","volume":"59","author":"Goodman","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0075","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0272-6386(97)90352-8","article-title":"Are we mismanaging calcium and phosphate metabolism in renal failure?","volume":"29","author":"Hsu","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 73","key":"10.1046\/j.1523-1755.2003.00720.x_bb0080","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1046\/j.1523-1755.1999.07307.x","article-title":"What is the optimal regimen for vitamin D?","volume":"56","author":"Cunningham","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0085","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphophatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0090","first-page":"1083","article-title":"Allosteric activation of the calcium receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568","volume":"53","author":"Hammerland","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0095","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0100","series-title":"Principles in Bone Biology","first-page":"1019","article-title":"Calcium receptors as novel drug targets","author":"Nemeth","year":"1996"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0110","first-page":"295","article-title":"Hyperparathyroidism and dialysis vintage","volume":"54","author":"Chertow","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0115","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum phosphorus, calcium x phosphorus product and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 73","key":"10.1046\/j.1523-1755.2003.00720.x_bb0120","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1046\/j.1523-1755.1999.07316.x","article-title":"Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consenquences","volume":"56","author":"Llach","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0125","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0130","series-title":"Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"81","article-title":"Parathyroid hormone","author":"Juppner","year":"1999"},{"key":"10.1046\/j.1523-1755.2003.00720.x_bb0135","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1152\/ajpcell.2001.280.2.C382","article-title":"Expression of extracellular calcium sensing receptor in human osteoblastic MG-63 cell line","volume":"280","author":"Yamaguchi","year":"2001","journal-title":"Am J Cell Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815488660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815488660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T04:41:50Z","timestamp":1622868110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815488660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0085253815488660"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00720.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}